Piperidine

Piperidine

SCHEMBL9404500

C1CCNCC1.OCC(O)N1CCCCC1

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.34
ATM Q13315 1/20 0.34
CA2 P00918 1/20 0.33
CHKA P35790 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
FDPS P14324 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL669829 0.87 MAPT (0.42) MAPTATMMEN1KMT2AFDPS
SCHEMBL3261592 0.84
SCHEMBL12244538 0.84
SCHEMBL10537680 0.82 MEN1 (0.34) MAPTATMCA2MEN1KMT2A
SCHEMBL12529886 0.79
Pyrrolidine SCHEMBL2361768 0.76 GBA1 (0.30)
Pyrrolidine SCHEMBL2361731 0.76 GBA1 (0.30)
SCHEMBL11500196 0.74 MAPT (0.42) ALDH1A1MAPTATMMEN1KMT2A
SCHEMBL22711078 0.72 OPRM1 (0.34)
Piperidine SCHEMBL4181536 0.72 ATM (0.73) ALDH1A1MAPTATMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5304548-A Tether composition joining two furochromones THE UPJOHN COMPANY (US) 1994-04-19 US claimed
EP-0429464-A1 BIVALENT LIGANDS EFFECTIVE FOR BLOCKING ACAT ENZYME. UPJOHN CO (US) 1991-06-05 EP claimed
WO-1990002129-A1 BIVALENT LIGANDS EFFECTIVE FOR BLOCKING ACAT ENZYME THE UPJOHN COMPANY (US) 1990-03-08 WO claimed
EP-0429464-B1 BIVALENT LIGANDS EFFECTIVE FOR BLOCKING ACAT ENZYME UPJOHN CO (US) 1994-11-23 EP disclosed
US-5304548-A Tether composition joining two furochromones THE UPJOHN COMPANY (US) 1994-04-19 US disclosed
US-5180717-A Atherosclerosis treatment and antilipemic agents THE UPJOHN COMPANY (US) 1993-01-19 US disclosed
EP-0429464-A1 BIVALENT LIGANDS EFFECTIVE FOR BLOCKING ACAT ENZYME. UPJOHN CO (US) 1991-06-05 EP disclosed
WO-1990002129-A1 BIVALENT LIGANDS EFFECTIVE FOR BLOCKING ACAT ENZYME THE UPJOHN COMPANY (US) 1990-03-08 WO disclosed